C4 Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.About CCCC
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.
CEOAndrew J. Hirsch
CEOAndrew J. Hirsch
Employees110
Employees110
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2015
Founded2015
Employees110
Employees110
CCCC Key Statistics
Market cap182.55M
Market cap182.55M
Price-Earnings ratio-1.59
Price-Earnings ratio-1.59
Dividend yield—
Dividend yield—
Average volume869.34K
Average volume869.34K
High today$2.72
High today$2.72
Low today$2.50
Low today$2.50
Open price$2.50
Open price$2.50
Volume1.13M
Volume1.13M
52 Week high$7.22
52 Week high$7.22
52 Week low$1.09
52 Week low$1.09
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own CCCC. This list is generated using Robinhood data, and it’s not a recommendation.